DRKS00028259招募中不适用
Evaluation of ctDNA as a prognostic marker in gastric cancer or adenocarcinomas of the gastroesophageal junction - a prospective observational study - ctDNA
niversitätsklinikum Ulm0 个研究点目标入组 10 人开始时间: 2022年6月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Patients with GEJ/stomach adenocarcinoma scheduled for curative-intent treatment by perioperative chemo(radio)therapy and surgery
- •2. Ability of subject to understand character and individual consequences of the clinical trial
- •3. Age = 18 years
- •4. Written informed consent
排除标准
- •1. Participation in an interventional trial with interference of procedures and/or outcome of this study
- •2. Patients with a legal guardian
研究者
相似试验
已完成
不适用
Prospective study evaluating ctDNA as a biomarker for treatment response in head and neck squamous cell carcinoma*NL-OMON46578Antoni van Leeuwenhoek Ziekenhuis70
已完成
不适用
cfDNA as a predictive marker for the prognosis of severe courses in patients with influenza-like symptoms with and without SARS-CoV-2 infections in General Practice: A prospective cohort study.J06.9U07.1Acute upper respiratory infection, unspecifiedCOVID-19, virus identifiedDRKS00024722Institut für Allgemeinmedizin, Universitätsklinikum Essen74
招募中
不适用
Clinical efficacy of ctDNA dynamics before and after total neoadjuvant treatment in locally adjuvant rectal cancer.KCT0008155Chonnam National University Hospital Hwasun Hospital45
Unknown
不适用
ctDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal CancerColorectal CancerNCT03312374Sun Yat-sen University350
招募中
不适用
Genetic analysis of prognosis-related factors in gliomas: methylation of MGMT, LOH of 1p/19q, and mutation of IDH1/2.GliomaJPRN-UMIN000003196Yokohama City University of Medicine100